ID   SYVM_HUMAN              Reviewed;        1063 AA.
AC   Q5ST30; A2ABL7; B4DET4; B4E3P5; F5GXJ0; F5H323; Q2M2A0; Q59FI1; Q5SQ96;
AC   Q5SS98; Q6DKJ5; Q6ZV24; Q96GN2; Q96H77; Q96Q02; Q9H6R2; Q9UFH7;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   07-APR-2021, entry version 158.
DE   RecName: Full=Valine--tRNA ligase, mitochondrial;
DE            EC=6.1.1.9;
DE   AltName: Full=Valyl-tRNA synthetase;
DE            Short=ValRS;
DE   AltName: Full=Valyl-tRNA synthetase-like;
DE   Flags: Precursor;
GN   Name=VARS2; Synonyms=KIAA1885, VARS2L, VARSL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLN-1049.
RC   TISSUE=Brain;
RX   PubMed=11572484; DOI=10.1093/dnares/8.4.179;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XXI. The
RT   complete sequences of 60 new cDNA clones from brain which code for large
RT   proteins.";
RL   DNA Res. 8:179-187(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 4), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 416-1063 (ISOFORM 1), AND VARIANTS ARG-449;
RP   LEU-680; GLN-917 AND THR-965.
RC   TISSUE=Cerebellum, Thalamus, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS ARG-449;
RP   LEU-680 AND THR-965.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS ARG-449;
RP   LEU-680; GLN-917; THR-965 AND GLN-1049.
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS ARG-449;
RP   LEU-680; GLN-917; THR-965 AND GLN-1049.
RC   TISSUE=Brain, Eye, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 748-1063 (ISOFORM 1), AND VARIANT
RP   THR-965.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   INVOLVEMENT IN COXPD20, VARIANT COXPD20 ILE-337, AND CHARACTERIZATION OF
RP   VARIANT COXPD20 ILE-337.
RX   PubMed=24827421; DOI=10.1002/humu.22590;
RA   Diodato D., Melchionda L., Haack T.B., Dallabona C., Baruffini E.,
RA   Donnini C., Granata T., Ragona F., Balestri P., Margollicci M.,
RA   Lamantea E., Nasca A., Powell C.A., Minczuk M., Strom T.M., Meitinger T.,
RA   Prokisch H., Lamperti C., Zeviani M., Ghezzi D.;
RT   "VARS2 and TARS2 mutations in patients with mitochondrial
RT   encephalomyopathies.";
RL   Hum. Mutat. 35:983-989(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   VARIANTS COXPD20 THR-349 AND ASP-596.
RX   PubMed=25058219; DOI=10.1001/jama.2014.7184;
RA   Taylor R.W., Pyle A., Griffin H., Blakely E.L., Duff J., He L.,
RA   Smertenko T., Alston C.L., Neeve V.C., Best A., Yarham J.W., Kirschner J.,
RA   Schara U., Talim B., Topaloglu H., Baric I., Holinski-Feder E., Abicht A.,
RA   Czermin B., Kleinle S., Morris A.A., Vassallo G., Gorman G.S., Ramesh V.,
RA   Turnbull D.M., Santibanez-Koref M., McFarland R., Horvath R.,
RA   Chinnery P.F.;
RT   "Use of whole-exome sequencing to determine the genetic basis of multiple
RT   mitochondrial respiratory chain complex deficiencies.";
RL   JAMA 312:68-77(2014).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-valine + tRNA(Val) = AMP + diphosphate + L-valyl-
CC         tRNA(Val); Xref=Rhea:RHEA:10704, Rhea:RHEA-COMP:9672, Rhea:RHEA-
CC         COMP:9708, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57762,
CC         ChEBI:CHEBI:78442, ChEBI:CHEBI:78537, ChEBI:CHEBI:456215; EC=6.1.1.9;
CC   -!- INTERACTION:
CC       Q5ST30; Q8IZP0-5: ABI1; NbExp=3; IntAct=EBI-2116622, EBI-11743294;
CC       Q5ST30; Q9NYB9-2: ABI2; NbExp=3; IntAct=EBI-2116622, EBI-11096309;
CC       Q5ST30; Q9P2A4: ABI3; NbExp=3; IntAct=EBI-2116622, EBI-742038;
CC       Q5ST30; O43639: NCK2; NbExp=3; IntAct=EBI-2116622, EBI-713635;
CC       Q5ST30; O60504: SORBS3; NbExp=3; IntAct=EBI-2116622, EBI-741237;
CC       Q5ST30-3; Q96DZ9: CMTM5; NbExp=3; IntAct=EBI-10244969, EBI-2548702;
CC       Q5ST30-3; Q969L2: MAL2; NbExp=3; IntAct=EBI-10244969, EBI-944295;
CC       Q5ST30-4; Q9NYB9: ABI2; NbExp=3; IntAct=EBI-10244997, EBI-743598;
CC       Q5ST30-4; O43639: NCK2; NbExp=3; IntAct=EBI-10244997, EBI-713635;
CC       Q5ST30-4; O60504: SORBS3; NbExp=3; IntAct=EBI-10244997, EBI-741237;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q5ST30-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5ST30-2; Sequence=VSP_034032;
CC       Name=3;
CC         IsoId=Q5ST30-3; Sequence=VSP_045483;
CC       Name=4;
CC         IsoId=Q5ST30-4; Sequence=VSP_046102;
CC   -!- DISEASE: Combined oxidative phosphorylation deficiency 20 (COXPD20)
CC       [MIM:615917]: A disorder due to mitochondrial respiratory chain complex
CC       defects. Clinical features are variable and include muscle weakness
CC       with hypotonia, central neurological disease with progressive external
CC       ophthalmoplegia, ptosis and ataxia, delayed psychomotor development,
CC       cardiomyopathy, abnormal liver function, facial dysmorphism,
CC       microcephaly and epilepsy. {ECO:0000269|PubMed:24827421,
CC       ECO:0000269|PubMed:25058219}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15191.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB67778.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAD92716.1; Type=Miscellaneous discrepancy; Note=The sequence differs from that shown because it seems to be derived from a pre-mRNA.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB067472; BAB67778.1; ALT_INIT; mRNA.
DR   EMBL; AK025618; BAB15191.1; ALT_INIT; mRNA.
DR   EMBL; AK125069; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK293780; BAG57195.1; -; mRNA.
DR   EMBL; AK304807; BAG65557.1; -; mRNA.
DR   EMBL; AB209479; BAD92716.1; ALT_SEQ; Transcribed_RNA.
DR   EMBL; AL662854; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL669830; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL773541; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX927194; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR759747; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR936875; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC008844; AAH08844.2; -; mRNA.
DR   EMBL; BC009355; AAH09355.2; -; mRNA.
DR   EMBL; BC073838; AAH73838.1; -; mRNA.
DR   EMBL; BC112054; AAI12055.1; -; mRNA.
DR   EMBL; BC113605; AAI13606.1; -; mRNA.
DR   EMBL; AL122037; CAB59177.1; -; mRNA.
DR   CCDS; CCDS34387.1; -. [Q5ST30-1]
DR   CCDS; CCDS54980.1; -. [Q5ST30-4]
DR   CCDS; CCDS54981.1; -. [Q5ST30-3]
DR   RefSeq; NP_001161205.1; NM_001167733.2. [Q5ST30-3]
DR   RefSeq; NP_001161206.1; NM_001167734.1. [Q5ST30-4]
DR   RefSeq; NP_065175.4; NM_020442.5. [Q5ST30-1]
DR   BioGRID; 121426; 84.
DR   IntAct; Q5ST30; 16.
DR   MINT; Q5ST30; -.
DR   STRING; 9606.ENSP00000441000; -.
DR   iPTMnet; Q5ST30; -.
DR   PhosphoSitePlus; Q5ST30; -.
DR   BioMuta; VARS2; -.
DR   DMDM; 296452917; -.
DR   EPD; Q5ST30; -.
DR   jPOST; Q5ST30; -.
DR   MassIVE; Q5ST30; -.
DR   MaxQB; Q5ST30; -.
DR   PaxDb; Q5ST30; -.
DR   PeptideAtlas; Q5ST30; -.
DR   PRIDE; Q5ST30; -.
DR   ProteomicsDB; 24437; -.
DR   ProteomicsDB; 26145; -.
DR   ProteomicsDB; 63892; -. [Q5ST30-1]
DR   ProteomicsDB; 63893; -. [Q5ST30-2]
DR   Antibodypedia; 45126; 53 antibodies.
DR   Ensembl; ENST00000321897; ENSP00000316092; ENSG00000137411. [Q5ST30-1]
DR   Ensembl; ENST00000415079; ENSP00000400867; ENSG00000223494. [Q5ST30-1]
DR   Ensembl; ENST00000541562; ENSP00000441000; ENSG00000137411. [Q5ST30-1]
DR   Ensembl; ENST00000546854; ENSP00000446839; ENSG00000223494. [Q5ST30-4]
DR   Ensembl; ENST00000625423; ENSP00000485818; ENSG00000137411. [Q5ST30-3]
DR   Ensembl; ENST00000676266; ENSP00000502585; ENSG00000137411. [Q5ST30-1]
DR   GeneID; 57176; -.
DR   KEGG; hsa:57176; -.
DR   UCSC; uc003nsc.3; human. [Q5ST30-1]
DR   CTD; 57176; -.
DR   DisGeNET; 57176; -.
DR   GeneCards; VARS2; -.
DR   HGNC; HGNC:21642; VARS2.
DR   HPA; ENSG00000137411; Low tissue specificity.
DR   MalaCards; VARS2; -.
DR   MIM; 612802; gene.
DR   MIM; 615917; phenotype.
DR   neXtProt; NX_Q5ST30; -.
DR   OpenTargets; ENSG00000137411; -.
DR   Orphanet; 420728; Combined oxidative phosphorylation defect type 20.
DR   PharmGKB; PA164742816; -.
DR   VEuPathDB; HostDB:ENSG00000137411.16; -.
DR   eggNOG; KOG0432; Eukaryota.
DR   GeneTree; ENSGT00940000159890; -.
DR   InParanoid; Q5ST30; -.
DR   OMA; RQWYIRN; -.
DR   PhylomeDB; Q5ST30; -.
DR   TreeFam; TF354250; -.
DR   PathwayCommons; Q5ST30; -.
DR   Reactome; R-HSA-379726; Mitochondrial tRNA aminoacylation.
DR   BioGRID-ORCS; 57176; 394 hits in 997 CRISPR screens.
DR   ChiTaRS; VARS2; human.
DR   GenomeRNAi; 57176; -.
DR   Pharos; Q5ST30; Tbio.
DR   PRO; PR:Q5ST30; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q5ST30; protein.
DR   Bgee; ENSG00000137411; Expressed in right hemisphere of cerebellum and 211 other tissues.
DR   ExpressionAtlas; Q5ST30; baseline and differential.
DR   Genevisible; Q5ST30; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004832; F:valine-tRNA ligase activity; IBA:GO_Central.
DR   GO; GO:0006438; P:valyl-tRNA aminoacylation; IBA:GO_Central.
DR   CDD; cd07962; Anticodon_Ia_Val; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   Gene3D; 3.90.740.10; -; 2.
DR   InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR   InterPro; IPR002300; aa-tRNA-synth_Ia.
DR   InterPro; IPR033705; Anticodon_Ia_Val.
DR   InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit.
DR   InterPro; IPR002303; Valyl-tRNA_ligase.
DR   Pfam; PF08264; Anticodon_1; 1.
DR   Pfam; PF00133; tRNA-synt_1; 1.
DR   PRINTS; PR00986; TRNASYNTHVAL.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   SUPFAM; SSF50677; SSF50677; 1.
DR   TIGRFAMs; TIGR00422; valS; 1.
DR   PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Aminoacyl-tRNA synthetase; ATP-binding;
KW   Disease variant; Ligase; Mitochondrion; Nucleotide-binding;
KW   Primary mitochondrial disease; Protein biosynthesis; Reference proteome;
KW   Transit peptide.
FT   TRANSIT         1..26
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..1063
FT                   /note="Valine--tRNA ligase, mitochondrial"
FT                   /id="PRO_0000338000"
FT   MOTIF           146..156
FT                   /note="'HIGH' region"
FT   MOTIF           658..662
FT                   /note="'KMSKS' region"
FT   BINDING         661
FT                   /note="ATP"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..644
FT                   /note="MPHLPLASFRPPFWGLRHSRGLPRFHSVSTQSEPHGSPISRRNREAKQKRLR
FT                   EKQATLEAEIAGESKSPAESIKAWRPKELVLYEIPTKPGEKKDVSGPLPPAYSPRYVEA
FT                   AWYPWWVREGFFKPEYQARLPQATGETFSMCIPPPNVTGSLHIGHALTVAIQDALVRWH
FT                   RMRGDQVLWVPGSDHAGIATQAVVEKQLWKERGVRRHELSREAFLREVWQWKEAKGGEI
FT                   CEQLRALGASLDWDRECFTMDVGSSVAVTEAFVRLYKAGLLYRNHQLVNWSCALRSAIS
FT                   DIEVENRPLPGHTQLRLPGCPTPVSFGLLFSVAFPVDGEPDAEVVVGTTRPETLPGDVA
FT                   VAVHPDDSRYTHLHGRQLRHPLMGQPLPLITDYAVQPHVGTGAVKVTPAHSPADAEMGA
FT                   RHGLSPLNVIAEDGTMTSLCGDWLQGLHRFVAREKIMSVLSEWGLFRGLQNHPMVLPIC
FT                   SRSGDVIEYLLKNQWFVRCQEMGARAAKAVESGALELSPSFHQKNWQHWFSHIGDWCVS
FT                   RQLWWGHQIPAYLVVEDHAQGEEDCWVVGRSEAEAREVAAELTGRPGAELTLERDPDVL
FT                   DTWFSSALFPFSALGWPQETPDLARFYPLSLLETGSDLLLFWVGRMVMLGTQLTGQLPF
FT                   SK -> MVFFCPVPLFCPGLAPRDPRPCSFLPPVTFGNGQRPSAVLGGPHGHVGDPAHR
FT                   AAALQQVWRPEIPRHLQGNPPLLTPPCPQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_034032"
FT   VAR_SEQ         1..140
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045483"
FT   VAR_SEQ         1
FT                   /note="M -> MGGKAWPRRAVGTAGGPCAEQISAPFQTLLM (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046102"
FT   VARIANT         26
FT                   /note="H -> Y (in dbSNP:rs6926224)"
FT                   /id="VAR_052651"
FT   VARIANT         64
FT                   /note="G -> R (in dbSNP:rs6926723)"
FT                   /id="VAR_043730"
FT   VARIANT         337
FT                   /note="T -> I (in COXPD20; decreased levels of the protein;
FT                   dbSNP:rs587777585)"
FT                   /evidence="ECO:0000269|PubMed:24827421"
FT                   /id="VAR_071850"
FT   VARIANT         349
FT                   /note="A -> T (in COXPD20; dbSNP:rs587777583)"
FT                   /evidence="ECO:0000269|PubMed:25058219"
FT                   /id="VAR_071851"
FT   VARIANT         449
FT                   /note="W -> R (in dbSNP:rs2249464)"
FT                   /evidence="ECO:0000269|PubMed:14574404,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|Ref.3"
FT                   /id="VAR_043731"
FT   VARIANT         596
FT                   /note="A -> D (in COXPD20; dbSNP:rs587777584)"
FT                   /evidence="ECO:0000269|PubMed:25058219"
FT                   /id="VAR_071852"
FT   VARIANT         680
FT                   /note="V -> L (in dbSNP:rs2074506)"
FT                   /evidence="ECO:0000269|PubMed:14574404,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|Ref.3"
FT                   /id="VAR_043732"
FT   VARIANT         765
FT                   /note="V -> M (in dbSNP:rs55865499)"
FT                   /id="VAR_061910"
FT   VARIANT         917
FT                   /note="R -> Q (in dbSNP:rs9394021)"
FT                   /evidence="ECO:0000269|PubMed:14574404,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_043733"
FT   VARIANT         965
FT                   /note="A -> T (in dbSNP:rs2252863)"
FT                   /evidence="ECO:0000269|PubMed:14574404,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17974005, ECO:0000269|Ref.3"
FT                   /id="VAR_043734"
FT   VARIANT         1049
FT                   /note="R -> Q (in dbSNP:rs4678)"
FT                   /evidence="ECO:0000269|PubMed:11572484,
FT                   ECO:0000269|PubMed:14574404, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_043735"
FT   CONFLICT        25
FT                   /note="F -> S (in Ref. 2; BAG65557)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        156
FT                   /note="H -> R (in Ref. 2; BAG57195)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        985
FT                   /note="E -> G (in Ref. 2; BAB15191)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1060
FT                   /note="S -> G (in Ref. 2; BAG65557)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1063 AA;  118490 MW;  0212C6361A87DF8B CRC64;
     MPHLPLASFR PPFWGLRHSR GLPRFHSVST QSEPHGSPIS RRNREAKQKR LREKQATLEA
     EIAGESKSPA ESIKAWRPKE LVLYEIPTKP GEKKDVSGPL PPAYSPRYVE AAWYPWWVRE
     GFFKPEYQAR LPQATGETFS MCIPPPNVTG SLHIGHALTV AIQDALVRWH RMRGDQVLWV
     PGSDHAGIAT QAVVEKQLWK ERGVRRHELS REAFLREVWQ WKEAKGGEIC EQLRALGASL
     DWDRECFTMD VGSSVAVTEA FVRLYKAGLL YRNHQLVNWS CALRSAISDI EVENRPLPGH
     TQLRLPGCPT PVSFGLLFSV AFPVDGEPDA EVVVGTTRPE TLPGDVAVAV HPDDSRYTHL
     HGRQLRHPLM GQPLPLITDY AVQPHVGTGA VKVTPAHSPA DAEMGARHGL SPLNVIAEDG
     TMTSLCGDWL QGLHRFVARE KIMSVLSEWG LFRGLQNHPM VLPICSRSGD VIEYLLKNQW
     FVRCQEMGAR AAKAVESGAL ELSPSFHQKN WQHWFSHIGD WCVSRQLWWG HQIPAYLVVE
     DHAQGEEDCW VVGRSEAEAR EVAAELTGRP GAELTLERDP DVLDTWFSSA LFPFSALGWP
     QETPDLARFY PLSLLETGSD LLLFWVGRMV MLGTQLTGQL PFSKVLLHPM VRDRQGRKMS
     KSLGNVLDPR DIISGVEMQV LQEKLRSGNL DPAELAIVAA AQKKDFPHGI PECGTDALRF
     TLCSHGVQAG DLHLSVSEVQ SCRHFCNKIW NALRFILNAL GEKFVPQPAE ELSPSSPMDA
     WILSRLALAA QECERGFLTR ELSLVTHALH HFWLHNLCDV YLEAVKPVLW HSPRPLGPPQ
     VLFSCADLGL RLLAPLMPFL AEELWQRLPP RPGCPPAPSI SVAPYPSACS LEHWRQPELE
     RRFSRVQEVV QVLRALRATY QLTKARPRVL LQSSEPGDQG LFEAFLEPLG TLGYCGAVGL
     LPPGAAAPSG WAQAPLSDTA QVYMELQGLV DPQIQLPLLA ARRYKLQKQL DSLTARTPSE
     GEAGTQRQQK LSSLQLELSK LDKAASHLRQ LMDEPPAPGS PEL
//
